In vitro immune modulation by antibodies coupled to tumour cells

Gene Therapy

Volumn 4, Issue 12, 1997, Pages 1350-1360

  Darling, D ^a,b   Galea Lauri, J ^a   Gaken J ^a   Towner, P ^a   Kuiper, M ^a   Hollingsworth, S ^a   Hirst, W ^a   Barnard, A ^a   Buggins, A ^a   Mufti, G ^a   Farzaneh, F ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antibody; Avidin; Biotin; CD28; CD3; Immunotherapy

Indexed keywords

ANTIBODY; AVIDIN; BIOTIN; CD28 ANTIGEN; CELL SURFACE PROTEIN; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; SUCCINIMIDE DERIVATIVE;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

ANIMALIA;

EID: 6844239558     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300534     Document Type: Article

References (26)

1. Marcel T, Grauz DJ. The TMC worldwide gene therapy enrolment report (June 1996). Hum Gene Ther 1996; 7: 2025-2046.
2. McHugh RS et al. Construction, purification, and functional incorporation on tumour cells of glycolipid-anchored human B7-1 (CD80). Proc Natl Acad Sci USA 1995, 92: 8059-8063.
3. Brunschwig EB, Levine E, Trefzner U, Tykocinski ML. Glycosyl-phosphatidylinositol-modified murine B7-1 and B7-2 retain costimulator function. J Immunol 1995; 155: 5498-5505.
4. Brunschwig EB, Fayen JD, Tykocinski ML. Protein transfer of glycosyl-phosphatidylinositol (GPI)-modified murine B7-1 and B7-2 on to tumor cell surfaces. FASEB J 1996; 10: pA1348 (Abstr. 2012).
5. Brunschwig EB, Tykocinski ML. Glycosyl-phosphatidylinositol (GPD-modified murine B7-1 (mB7-1:GPI) retains costimulatory activity. FASEB J 1995; 9: pAS11 (Abstr. 4700).
6. + T cells B7-transfected melanoma cells. Science 1993; 259: 368-370.
7. Conrad MK, Lo MS. Facilitated cell fusion for hybridoma production. Meth Enzymol 1990; 184: 641-653.
8. Goward CR, Murphy JP, Atkinson T, Barstow DA. Expression and purification of a truncated recombinant protein G. Biochem J 1990; 267: 171-177.
9. Demant EJF, Jensen PB, Sehested M. Characterization of the cooperative cross-linking of doxorubicin N-hydroxysuccinimide ester derivatives to water soluble proteins. Biochim Biophys Acta 1991; 1118: 83-90.
10. Baroja ML, Lorré K, van Vaeck F, Ceuppens JL The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens. Cell Immunol 1989; 120: 205-217.
11. Nunes JA et al. The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras. J Exp Med 1994; 180: 1067-1078.
12. Muzykantov VR, Smirnov MD, Klibanov AL. Avidin attachment to red blood cells via a phospholipid derivative of biotm provides complement-resistant immunoerythrocytes. J Immunol Meth 1993; 158: 183-190.
13. Christiaansen JE et al. Rapid covalent coupling of proteins to cell surfaces: Immunological characterization of viable proteincell conjugates. J Immunol Meth 1984; 74: 229-239.
14. Johnstone A, Thorpe R. Coupling antibodies to fluorochromes, enzymes and biotin. In. Johnstone A, Thorpe R (eds). Immuiiochemistry in Practice. Blackwell Science: Oxford, 1996, pp 277-289.
15. Spiegel S, Wilchek M. Membrane sialoglycolipids emerging as possible signal transducers for lymphocyte stimulation J Immunol 1981; 127: 572-575.
16. Kähne T, Ansorge S. Nonradioactive labelling and imirrunoprecipitation analysis of leukocyte surface proteins using different methods of protein biotinylation. J Immunol Meth 1994; 168: 209-218.
17. De Clerk LS et al. Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function. J Immunol Meth 1994; 172: 115-124.
18. Walunas TL et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1: 405-413.
19. Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995; 182: 459-165.
20. Li YW, Hellström KE, Newby SA, Chen LP. Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumours. J Exp Med 1996; 183: 639-644.
21. Sano T, Cantor CR. A srreptavidin-protein A chimera that allows one-step production of a variety of specific antibody conjugates. Biotech NY 1991; 9: 1378-1381.
22. Kipriyanov SM et al. Affinity enhancement of a recombinant antibody - formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion. Protein Eng 1996; 9: 203-211.
23. Dalme NK, Doyle LV, Grosmaire LS, Ledbetter JA. Differential regulatory signals derived by antibody binding to the CD28 (Tp44) molecule during activation of human T lymphocytes. J Immunol 1988; 140: 1753-1761.
24. Dalme NK et al Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7 J Immunol 1994; 152: 2686-2697
25. Hyman R, Cunningham K, Stalling V. Evidence for a genetic basis for the class A thy-1-defect Immunogenetics 1980; 10: 261-271.
26. Gäken J, Farzaneh F, Stocking C, Ostertag W. Construction of a versatile set of retroviral vectors conferring hygromycin resistance. Biotechniques 1992, 13: 32-34.